Opening Scientific Plenary Session: Innovative and Practice Changing Concepts in GYN Oncology
Saturday, March 22, 2014: 8:00 AM-9:45 AM
Ballroom B/C (Tampa Convention Center)
Description:
Course Directors: Barbara A. Goff, MD, University of Washington Medical Center, Seattle, WA and Carol L. Brown, MD, Memorial Sloan Kettering Cancer Center, New York, NY
Moderators: Kathleen N. Moore, MD, The University of Oklahoma, Oklahoma City, OK
8:04 AM
Presentation of Foundation for Gynecologic Oncology Awards
R. D. Alvarez
University of Alabama at Birmingham, Birmingham, AL
8:06 AM
Foundation for Gynecologic Oncology: Humanitarian & Volunteerism Award
G. P. Parham
University of Alabama at Birmingham, Birmingham, AL
8:07 AM
Foundation for Gynecologic Oncology: Innovation Award
M. C. King1 and H. T. Lynch2
1University of Washington, Seattle, WA, 2Creighton's Hereditary Cancer Center, Omaha, NE
8:08 AM
Foundation for Gynecologic Oncology: Harry Long, MD Award
D. K. Armstrong
Johns Hopkins Kimmel Cancer Center, Baltimore, MD
8:09 AM
Foundation for Gynecologic Oncology: Distinguished Service Award presented to current ABOG Division Board Members
8:10 AM
Introductory Remarks
C. L. Brown1 and B. A. Goff2
1Memorial Sloan Kettering Cancer Center, New York, NY, 2University of Washington Medical Center, Seattle, WA
8:20 AM
Moderator Introductions
K. N. Moore
The University of Oklahoma, Oklahoma City, OK
8:36 AM
A randomized phase III trial of gemcitabine + docetaxel + bevacizumab or placebo as first-line treatment for metastatic uterine leiomyosarcoma (uLMS): a Gynecologic Oncology Group study
M. L. Hensley1, A. Miller2, D. M. O'Malley3, R. S. Mannel4, K. Behbakht5, J. N. Bakkum-Gamez6 and H. Michael7
1Memorial Sloan-Kettering Cancer Center, New York, NY, 2Gynecologic Oncology Group, Buffalo, NY, 3The Ohio State University, Columbus, OH, 4University of Oklahoma Health Sciences Center, Oklahoma City, OK, 5University of Colorado Denver, Aurora, CO, 6Mayo Clinic, Rochester, MN, 7Indiana University School of Medicine, Indianapolis, IN
8:47 AM
Comparison of the performance of human papillomavirus (HPV) primary screening strategies with cytology-based strategies: results from the ATHENA trial 3-year follow-up phase
T. C. Wright1, M. H. Stoler2, C. M. Behrens3, G. Zhang3 and A. Sharma3
1Columbia University, New York, NY, 2University of Virginia Health System, Charlottesville, VA, 3Roche Molecular Systems, Pleasanton, CA
8:58 AM
Lecturette
W. R. Brewster
University of North Carolina Lineberger Comprehensive Cancer Center, Chapel Hill, NC
9:03 AM
Bariatric surgery decreases the risk of uterine malignancy
K. K. Ward1, A. M. Roncancio2, N. R. Shah1, M. A. Davis1, C. C. Saenz1, M. T. McHale1 and S. C. Plaxe1
1UCSD Rebecca and John Moores Cancer Center, La Jolla, CA, 2The University of Texas School of Public Health, Houston, TX
9:14 AM
A cost-utility analysis of Gynecologic Oncology Group protocol 218: the importance of incorporating prospectively collected quality-of-life scores in health outcomes research
D. E. Cohn1, J. C. Barnett2, L. Wenzel3, B. J. Monk4, R. A. Burger5, E. Myers6 and L. J. Havrilesky6
1The Ohio State University, Columbus, OH, 2San Antonio Military Medical Center, Ft. Sam Houston, TX, 3University of California, Irvine, Irvine, CA, 4Creighton University School of Medicine, St. Joseph’s Hospital and Medical Center, Phoenix,, AZ, 5University of Pennsylvania, Philadelphia, PA, 6Duke University Medical Center, Durham, NC
9:25 AM
Lecturette: The TCGA Concept
K. N. Moore
The University of Oklahoma, Oklahoma City, OK
9:41 AM
Questions/Floor Discussion
